Semaglutide is a medication primarily used for weight management and diabetes treatment. The dosing schedule typically involves a gradual increase in dosage over time to help the body adjust and maximize efficacy while minimizing side effects. Below is a general dosing chart for semaglutide, particularly focusing on the injectable form.
| Condition | Dosage | Duration |
|---|---|---|
| Type 2 Diabetes | 0.25 mg (initial dose) | 4 weeks (to reduce side effects) |
| 0.5 mg (maintenance dose) | After initial dose, ongoing as needed | |
| 1 mg (higher maintenance dose) | For patients needing further glucose control | |
| Weight Management | 0.25 mg (initial dose) | 4 weeks (starting dose) |
| 0.5 mg (step-up dose) | Typically after 4 weeks | |
| 1 mg (step-up dose) | Gradually increased as needed | |
| 1.7 mg (optional step-up) | If higher dosage is needed | |
| 2.4 mg (target dose) | Final maintenance dose |
Important Considerations:
- Injection: Semaglutide is administered as a weekly injection.
- Injection Site: Typically injected subcutaneously (under the skin) in the abdomen, thigh, or upper arm.
- Timing: Can be taken on any day of the week, with or without food.
- Side Effects: Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain. These often improve over time.
If you experience significant side effects or have any concerns, contact your healthcare provider.
Sources used: